Search

everythinglearnresearchcommunity

for

Search:↓

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Patients with mycosis fungoides have a higher risk of heart disease.

Premature hair greying may indicate a higher risk of metabolic problems.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

People with male pattern baldness are more likely to have metabolic syndrome.

People with plantar corns and calluses may have a higher chance of having metabolic syndrome.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

There's no significant link between blood fat levels and male pattern baldness.

The intensive conventional diet with exercise led to better long-term weight loss and health improvements than the very low calorie diet in obese type 2 diabetics.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Cheonggukjang may help prevent and manage various diseases and improve overall health, but its odor and safety concerns need addressing.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Hidden fungal infections might cause heart disease and clogged arteries.

The patient with autoimmune hypothyroidism improved after treatment for thyroid and associated conditions.

Hair loss may increase heart disease risk.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Young women with PCOS and no other heart risk factors have normal heart function.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.